Académique Documents
Professionnel Documents
Culture Documents
Estimated Total Annual Burden other forms of information technology. Research (CBER). Nominations will be
Hours 3,600. Consideration will be given to accepted for vacancies that will or may
In compliance with the requirements comments and suggestions submitted occur through December 31, 2006.
of Section 3506(c)(2)(A) of the within 60 days of this publication. FDA has a special interest in ensuring
Paperwork Reduction Act of 1995, the Dated: February 9, 2006. that women, minority groups, and
Administration for Children and Robert Sargis,
individuals with disabilities are
Families is soliciting public comment adequately represented on advisory
Reports Clearance Officer.
on the specific aspects of the committees and, therefore, encourages
information collection described above. [FR Doc. 06–1402 Filed 2–14–06; 8:45 am] nominations of qualified candidates
Copies of the proposed collection of BILLING CODE 4184–01–M from these groups.
information can be obtained and DATES: Because scheduled vacancies
comments may be forwarded by writing occur on various dates throughout each
DEPARTMENT OF HEALTH AND
to the Administration for Children and year, no cutoff date is established for the
HUMAN SERVICES
Families, Office of Administration, receipt of nominations. However, when
Office of Information Services, 370 Food and Drug Administration possible, nominations should be
L’Enfant Promenade, SW., Washington, received at least 6 months before the
DC 20447, Attn: ACF Reports Clearance Request for Nominations for Voting date of scheduled vacancies for each
Officer. E-mail address: Members on Public Advisory year, as indicated in this notice.
infocollection@acf.hhs.gov. All requests Committees ADDRESSES: All nominations and
should be identified by the title of the curricula vitae should be sent to the
information collection. AGENCY: Food and Drug Administration,
contact person listed in the FOR FURTHER
The Department specifically requests HHS.
INFORMATION CONTACT section of this
comments on: (a) Whether the proposed ACTION: Notice. document.
collection of information is necessary
for the proper performance of the SUMMARY: The Food and Drug FOR FURTHER INFORMATION CONTACT:
functions of the agency, including Administration (FDA) is requesting Donald Jehn, Division of Scientific
whether the information shall have nominations for voting members to Advisors and Consultants, Center for
practical utility; (b) the accuracy of the serve on the Allergenic Products Biologics Evaluation and Research
agency’s estimate of the burden of the Advisory Committee, Blood Products (HFM–71), Food and Drug
proposed collection of information; (c) Advisory Committee, Cellular, Tissue Administration, 1401 Rockville Pike,
the quality, utility, and clarity of the and Gene Therapies Advisory Rockville, MD 20852–1448, 301–827–
information to be collected; and (d) Committee, Transmissible Spongiform 0314, e-mail: donald.jehn@fda.hhs.gov.
ways to minimize the burden of the Encephalopathies Advisory Committee, SUPPLEMENTARY INFORMATION: FDA is
collection of information on and the Vaccines and Related Biological requesting nominations of voting
respondents, including through the use Products Advisory Committee in the members with appropriate expertise for
of automated collection techniques or Center for Biologics Evaluation and vacancies listed as follows:
TABLE 1.
Advisory Committee and Expertise Needed to Fill Vacan- Approximate Date Members are Need-
No. of Vacancies
cies ed
VerDate Aug<31>2005 13:17 Feb 14, 2006 Jkt 208001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\15FEN1.SGM 15FEN1
7974 Federal Register / Vol. 71, No. 31 / Wednesday, February 15, 2006 / Notices
TABLE 1.—Continued
Advisory Committee and Expertise Needed to Fill Vacan- Approximate Date Members are Need-
No. of Vacancies
cies ed
Cellular, Tissue, and Gene Therapies Advisory Com- 2 March 31, 2006
mittee—cellular therapies, tissue transplantation, gene
transfer therapies and xenotransplantation including bio-
statistics, bioethics, hematology/oncology, human tissues
and transplantation, reproductive medicine, general med-
icine and various medical specialties including surgery
and oncology, immunology, virology, molecular biology,
cell biology, developmental biology, tumor biology, bio-
chemistry, rDNA technology, nuclear medicine, gene
therapy, infectious diseases, and cellular kinetics
VerDate Aug<31>2005 13:17 Feb 14, 2006 Jkt 208001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\15FEN1.SGM 15FEN1